Polomar Health Services, Inc. financial data

Symbol
PMHS on OTC
Location
Palm Harbor, FL
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 25 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 10.3 % -24.5%
Quick Ratio 6.72 %
Debt-to-equity 16.9 % +11.4%
Return On Equity -29.6 % +14.6%
Return On Assets -25.3 % +7.84%
Operating Margin -6.2K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 28.1M shares
Common Stock, Shares, Outstanding 28M shares +1.31%
Entity Public Float 1.29M USD -96.7%
Common Stock, Value, Issued 28K USD +1.32%
Weighted Average Number of Shares Outstanding, Basic 28M shares +1.28%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 37K USD -37.4%
Cost of Revenue 16.6K USD +86.8%
Selling and Marketing Expense 50.7K USD +20.6%
General and Administrative Expense 2.27M USD +217%
Operating Income (Loss) -2.3M USD -212%
Nonoperating Income (Expense) -21K USD -72.4%
Net Income (Loss) Attributable to Parent -2.43M USD -224%
Earnings Per Share, Basic 0 USD/shares -100%
Earnings Per Share, Diluted 0 USD/shares -100%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 38.9K USD
Inventory, Net 159K USD +13.5%
Other Assets, Current 12.1K USD
Assets, Current 198K USD +26.6%
Property, Plant and Equipment, Net 52.9K USD -39.7%
Operating Lease, Right-of-Use Asset 23.6K USD -58.9%
Goodwill 250K USD
Other Assets, Noncurrent 9.02M USD -10.3%
Assets 9.27M USD -9.96%
Liabilities, Current 1.5M USD +57.6%
Operating Lease, Liability, Noncurrent 5.99K USD
Liabilities 1.5M USD +53.8%
Retained Earnings (Accumulated Deficit) -4.62M USD -111%
Stockholders' Equity Attributable to Parent 7.77M USD -16.6%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 114K USD
Liabilities and Equity 9.27M USD -9.96%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -45.6K USD +72.3%
Net Cash Provided by (Used in) Financing Activities 169K USD -25.2%
Net Cash Provided by (Used in) Investing Activities -41.5K USD
Common Stock, Shares Authorized 295M shares 0%
Common Stock, Shares, Issued 28M shares +1.31%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 123K USD +542%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 15.1K USD +228%
Interest Paid, Excluding Capitalized Interest, Operating Activities 41.4K USD
Deferred Tax Assets, Valuation Allowance 971K USD +111%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure
Payments to Acquire Property, Plant, and Equipment 41.5K USD
Property, Plant and Equipment, Gross 41.5K USD +1.7%
Operating Lease, Liability, Current 23.6K USD
Deferred Tax Assets, Operating Loss Carryforwards 971K USD +111%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Additional Paid in Capital 12.4M USD +7.66%
Preferred Stock, Shares Outstanding 500K shares
Current Federal Tax Expense (Benefit) 3.37M USD +94.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares